Iris Ciba
Doktorand vid Institutionen för kvinnors och barns hälsa; Pediatrisk inflammations- och metabolismforskning samt barnhälsa
- E-post:
- iris.ciba@uu.se
- Besöksadress:
- MTC-huset, Dag Hammarskjölds väg 14B, 1 tr
752 37 Uppsala - Postadress:
- Akademiska sjukhuset
751 85 UPPSALA - Tillgänglig:
- Barnsjukhuset
- Akademiska meriter:
- disputerad i Österrike
Mer information visas för dig som medarbetare om du loggar in.
Publikationer
Senaste publikationer
- Studies in children with obesity in two European treatment centres show a high prevalence of impaired glucose metabolism in the Swedish cohort (2024)
- Screening for inflammatory markers identifies IL18-Rα as a potential link between exenatide and its anti-inflammatory effect (2023)
- Adolescents with obesity treated with exenatide maintain endogenous GLP-1, reduce DPP-4, and improve glycemic control (2023)
- Metformin Can Attenuate Beta-Cell Hypersecretion-Implications for Treatment of Children with Obesity (2023)
- High levels of FSH before puberty are associated with increased risk of metabolic syndrome during pubertal transition (2022)
Alla publikationer
Artiklar
- Studies in children with obesity in two European treatment centres show a high prevalence of impaired glucose metabolism in the Swedish cohort (2024)
- Screening for inflammatory markers identifies IL18-Rα as a potential link between exenatide and its anti-inflammatory effect (2023)
- Adolescents with obesity treated with exenatide maintain endogenous GLP-1, reduce DPP-4, and improve glycemic control (2023)
- Metformin Can Attenuate Beta-Cell Hypersecretion-Implications for Treatment of Children with Obesity (2023)
- High levels of FSH before puberty are associated with increased risk of metabolic syndrome during pubertal transition (2022)
- Deviating glucose results in an international dual-center study. A root cause investigation (2022)
- Single Point Insulin Sensitivity Estimator in Pediatric Non-Alcoholic Fatty Liver Disease (2022)
- Association between alanine aminotransferase as surrogate of fatty liver disease and physical activity and sedentary time in adolescents with obesity (2022)
- Sedentary time has a stronger impact on metabolic health than moderate to vigorous physical activity in adolescents with obesity (2022)
- Association between Metabolic Syndrome Diagnosis and the Physical Activity-Sedentary Profile of Adolescents with Obesity (2022)
- Prevalence of different states of glucose intolerance in Sri Lankan children and adolescents with obesity and its relation to other comorbidities. (2021)
- Metabolic Abnormalities in a Cohort of Overweight and Obese Children in an Urban Setting of Sri Lanka (2021)
- A 6-month randomized, double-blind, placebo-controlled trial of weekly exenatide in adolescents with obesity (2020)
- Daily Assessments of Perceived Sensations in Obese and Non-Obese Children/Adolescents Using a New Mobile Application (2017)
- Exenatide Once Weekly Reduces Weight, Liver Fat And 2-Hour Postprandial Glucose In Obese Adolescents (2017)
- Effect of Glucose Load on the Incretin Response (GLP-1) in obese Adolescents compared to the normal-weight Adolescents (2017)
- Pancreatic Fat Is Associated With Metabolic Syndrome and Visceral Fat but Not Beta-Cell Function or Body Mass Index in Pediatric Obesity (2017)
- Eating Behavior In Swedish And Austrian Children And Adolescents With Obesity (2016)
- Altered Plasma Levels of Glucagon, GLP-1 and Glicentin During OGTT in Adolescents With Obesity and Type 2 Diabetes (2016)
- Development of Glucose Intolerance in Obese Children Studied in the Beta-Judo Cohort (2015)
- Early Adiposity Rebound and its Association with Obesity and Neuropsychiatric Disorders (2015)
- Deep Subcutaneous Adipose Tissue Correlates with Accentuated Insulin Secretion and Poor Insulin Sensitivity in Obese Children and Adolescents (2015)
- Pancreatic Fat is Associated with Metabolic Syndrome and Visceral Adipose Tissue but not Beta-Cell Function or Body Mass Index in Paediatric Obesity (2015)
- Uppsala Longitudinal Study of Childhood Obesity (2014)
- Screening of inflammatory markers finds hepatocyte growth factor to be associated with weight gain in children and adolescents with obesity